E25Bio scores $2m

Cambridge, Massachusetts-based E25Bio, a developer of rapid diagnostic tests, has raised $2 million in financing.

18 March 2020•1 min read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles